申请人:Philochem AG
公开号:EP4019507A1
公开(公告)日:2022-06-29
The present invention relates to ligands of Fibroblast Activation Protein (FAP) for the active delivery of various payloads (e.g. cytotoxic drugs, radionuclides, fluorophores, proteins and immunomodulators) at the site of disease. In particular, the present invention relates to the development of FAP ligands for targeting applications, in particular diagnostic methods and/or methods for therapy or surgery in relation to a disease or disorder, such as cancer, inflammation or another disease characterized by overexpression of FAP.
本发明涉及成纤维细胞活化蛋白(FAP)的配体,用于将各种有效载荷(如细胞毒性药物、放射性核素、荧光团、蛋白质和免疫调节剂)主动输送到疾病部位。特别是,本发明涉及开发用于靶向应用的 FAP 配体,尤其是与癌症、炎症或其他以 FAP 过度表达为特征的疾病或紊乱有关的诊断方法和/或治疗或手术方法。